61 related articles for article (PubMed ID: 10945157)
21. Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome--a functional approach.
Hillert A; Maier W; Wetzel H; Benkert O
Pharmacopsychiatry; 1992 Sep; 25(5):213-7. PubMed ID: 1384075
[TBL] [Abstract][Full Text] [Related]
22. Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected.
Agid O; Kapur S; Arenovich T; Zipursky RB
Arch Gen Psychiatry; 2003 Dec; 60(12):1228-35. PubMed ID: 14662555
[TBL] [Abstract][Full Text] [Related]
23. Therapeutical significance of clopimozide in the treatment of chronic psychotic patients.
De Cuyper HJ; Van Praag HM; Mulder WR
Acta Psychiatr Scand; 1979 May; 59(5):561-74. PubMed ID: 37697
[TBL] [Abstract][Full Text] [Related]
24. How long should treatments be continued?
Craig JC; Webster AC; Loy C
BMJ; 2010 Aug; 341():c4102. PubMed ID: 20724403
[No Abstract] [Full Text] [Related]
25. Testing the efficacy of new neuroleptic drugs.
Hirsch SR; Barnes TR
Psychopharmacol Ser; 1990; 8():26-36. PubMed ID: 1974048
[No Abstract] [Full Text] [Related]
26. New versus old neuroleptics: efficacy versus marketing.
von Gunten CF; Alici Y; Strouse TB; Pirrello R
J Palliat Med; 2013 Dec; 16(12):1509-14. PubMed ID: 24171545
[No Abstract] [Full Text] [Related]
27. SNP-based analysis of neuroactive ligand-receptor interaction pathways implicates PGE2 as a novel mediator of antipsychotic treatment response: data from the CATIE study.
Adkins DE; Khachane AN; McClay JL; Aberg K; Bukszár J; Sullivan PF; van den Oord EJ
Schizophr Res; 2012 Mar; 135(1-3):200-1. PubMed ID: 22099390
[No Abstract] [Full Text] [Related]
28. Double-blind design is also possible in cancer trials.
Prescrire Int; 2013 Nov; 22(143):263. PubMed ID: 24427835
[No Abstract] [Full Text] [Related]
29. Neuroleptics and psychic indifference.
Fleminger S
J R Soc Med; 1990 Jul; 83(7):475. PubMed ID: 1975628
[No Abstract] [Full Text] [Related]
30. The prospective, randomized, double-blind clinical trial in orthopaedic surgery.
Wehbé MA
J Bone Joint Surg Am; 1998 Sep; 80(9):1395. PubMed ID: 9759827
[No Abstract] [Full Text] [Related]
31. Limitations of controlled double-blind studies of drugs.
Cotzias GC
N Engl J Med; 1972 Nov; 287(18):937. PubMed ID: 4561673
[No Abstract] [Full Text] [Related]
32. [Planning and practice of clinical research: basic principles and errors as exemplified by Russian diabetology. A lecture].
Starostina EG; Antsiferov MB
Probl Endokrinol (Mosk); 1994; 40(6):38-41. PubMed ID: 7740036
[No Abstract] [Full Text] [Related]
33. Blurred vision.
Prescrire Int; 2015 May; 24(160):117. PubMed ID: 26034800
[No Abstract] [Full Text] [Related]
34. Double-blind trials and alternative medicine.
Hodson AH
J R Soc Med; 1993 Mar; 86(3):182. PubMed ID: 20894862
[No Abstract] [Full Text] [Related]
35. Double-blind studies.
Reich CJ
Can Med Assoc J; 1972 Feb; 106(4):307. PubMed ID: 20311870
[No Abstract] [Full Text] [Related]
36. The Double-Blind Design: A Theoretical Re-examination.
Hoffer A
Can Med Assoc J; 1968 Jan; 98(3):174. PubMed ID: 20329136
[No Abstract] [Full Text] [Related]
37. A theoretical examination of double-blind design.
Preshaw RM
Can Med Assoc J; 1967 Sep; 97(10):545. PubMed ID: 20329028
[No Abstract] [Full Text] [Related]
38. Open Literature.
Tolpin JG
Science; 1960 Dec; 132(3440):1679-80. PubMed ID: 17747272
[No Abstract] [Full Text] [Related]
39. Help for the Blind.
Br J Ophthalmol; 1920 Oct; 4(10):482. PubMed ID: 18168043
[No Abstract] [Full Text] [Related]
40. Literature for the Blind.
Br J Ophthalmol; 1918 Jan; 2(1):48-9. PubMed ID: 18167747
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
